Frank Pallone actually said...

We must not sacrifice safety and efficacy in exchange for innovation.

I would like to close by commenting on the importance of the Drug Safety Enhancement Act.

I think it is going to be very difficult to do any of these new innovations if we see a 21 percent cut.

I appreciate the need for the kinds of proposals listed under the heading of Advancing Regulatory Science and Innovation.